Headlands Research.
Profoundly Impacting the Clinical Trial Process.
Digital Content Producer | Marketing Strategy
Creative Marketing Strategy
Creation and management of all assets for marketing purposes for Headlands Research, a leading clinical research site network.
External marketing included social media management of over 12 social media accounts, content planning, lead system automation, lead generation, SEO optimization, website management, and creation of content.
Internal marketing included the creation and distribution of a company newsletter, corporate communications, and design of internal documents.
Patients are at the forefront of everything we do at Headlands Research. Our goal is to help improve quality of life by advancing prevention and treatments for serious health conditions.
We are proud to have served 15,514 patients in 2022. Patients are our core and fuel our mission to profoundly impact the clinical trial process.
Every one of our clinical research trials helps to further advance scientific discovery and patient quality of life.
In 2022, our site network conducted 408 clinical trials in more than 16 indications. In 2023, we remain steadfast in our mission to profoundly impact the clinical trials process. From Alzheimer’s disease to vaccines, we have physicians and sites in our network that work diligently to ensure our data is of the highest quality.
Our expansive clinical research site network serves patients across the United States and Canada. Every visit from one of our patients allows us to provide exceptional service and quality care.
This year our site network received 100,432 patient visits. We would like to thank our patients for entrusting Headlands Research with your health and helping us advance medicine.
This year the Davos Alzheimer’s Collaborative (DAC), an organization leading an unprecedented global response to Alzheimer’s disease, awarded our Toronto Memory Program site and RetiSpec a grant to launch a unique initiative to screen for AD.
This project implements a pragmatic and community-driven model to increase rates of cognitive testing and biological marker assessment for individuals aged 65 and older.
More Content.
